Regulation of alveolar fluid clearance and ENaC expression in lung by exogenous angiotensin II

Respiratory Physiology and Neurobiology

Volumn 181, Issue 1, 2012, Pages 53-61

  Deng, Jia ^a   Wang, Dao xin ^a   Deng, Wang ^a   Li, Chang yi ^a   Tong, Jin ^a   Ma, Hilary ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolar fluid clearance; Angiotensin II; Cyclic adenosine monophosphate; Epithelial sodium channel

Indexed keywords

ALPHA EPITHELIAL SODIUM CHANNEL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; BETA EPITHELIAL SODIUM CHANNEL; CYCLIC AMP; EPITHELIAL SODIUM CHANNEL; GAMMA EPITHELIAL SODIUM CHANNEL; MESSENGER RNA; UNCLASSIFIED DRUG; ZD 7155;

ALVEOLAR FLUID CLEARANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; INFLAMMATORY CELL; LUNG EDEMA; LUNG FLUID; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RESPIRATORY TRACT PARAMETERS;

ANGIOTENSIN II; ANIMALS; CYCLIC AMP; DOWN-REGULATION; EPITHELIAL SODIUM CHANNEL; EXTRAVASCULAR LUNG WATER; GENE EXPRESSION REGULATION; PULMONARY ALVEOLI; PULMONARY EDEMA; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; ROLIPRAM; WATER-ELECTROLYTE BALANCE;

EID: 84863240520     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2011.11.009     Document Type: Article

References (33)

1. Benos D.J., Saccomani G., Sariban-Sohraby S. The epithelial sodium channel. Subunit number and location of the amiloride binding site. J. Biol. Chem. 1987, 262:10613-10618.
2. Beutler K.T., Masilamani S., Turban S., Nielsen J., Brooks H.L., Ageloff S., Fenton R.A., Packer R.K., Knepper M.A. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003, 41:1143-1150.
3. Hatch M., Freel R.W. Increased colonic sodium absorption in rats with chronic renal failure is partially mediated by AT1 receptor agonism. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:348-356.
4. Butterworth M.B., Helman S.I., Els W.J. cAMP-sensitive endocytic trafficking in A6 epithelia. Am. J. Physiol. Cell Physiol. 2001, 280:752-762.
5. Chen X.J., Eaton D.C., Jain L. Beta-adrenergic regulation of amiloride-sensitive lung sodium channels. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 282:609-620.
6. Jain L., Chen X.J., Ramosevac S., Brown L.A., Eaton D.C. Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280:646-658.
7. Hager H., Kwon T.H., Vinnikova A.K., Masilamani S., Brooks H.L., Frøkiaer J., Knepper M.A., Nielsen S. Immunocytochemical and immunoelectron microscopic localization of alpha-, beta-, and gamma-ENaC in rat kidney. Am. J. Physiol. Renal Physiol. 2001, 280:1093-1106.
8. Harris P.J., Young J.A. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch. 1977, 367:295-297.
9. Inoue K., Takano H., Yanagisawa R., Sakurai M., Shimada A., Yoshino S., Sato H., Yoshikawa T. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp. Biol. Med. (Maywood), NJ 2005, 230:281-287.
10. Jensen A.M., Bae E.H., Fenton R.A., Nørregaard R., Nielsen S., Kim S.W., Frøkiaer J. Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction. Am. J. Physiol. Renal Physiol. 2009, 296:127-134.
11. Jernigan N.L., Speed J., LaMarca B., Granger J.P., Drummond H.A. Angiotensin II regulation of renal vascular ENaC proteins. Am. J. Hypertens. 2009, 22:593-597.
12. Johnson M.D., Bao H.F., Helms M.N., Chen X.J., Tigue Z., Jain L., Dobbs L.G., Eaton D.C. Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:4964-4969.
13. Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 2000, 52:11-34.
14. Levens N.R. Control of intestinal absorption by the renin-angiotensin system. Am. J. Physiol. 1985, 249:3-15.
15. Li X.C., Carretero O.A., Navar L.G., Zhuo J.L. AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases. Am. J. Physiol. Renal Physiol. 2006, 291:375-383.
16. Madala Halagappa V.K., Tiwari S., Riazi S., Hu X., Ecelbarger C.M. Chronic candesartan alters. Renal Physiol. 2008, 294:1222-12231.
17. Marshall R.P., Gohlke P., Chambers R.C., Howell D.C., Bottoms S.E., Unger T., McAnulty R.J., Laurent G.J. Angiotensin II and the fibroproliferative response to acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286:156-164.
18. Matalon S., O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu. Rev. Physiol. 1999, 61:627-661.
19. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
20. Miyoshi M., Miyano K., Moriyama N., Taniguchi M., Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation. Eur. J. Neurosci. 2008, 27:343-351.
21. Nakada T.A., Russell J.A., Boyd J.H., McLaughlin L., Nakada E., Thair S.A., Hirasawa H., Oda S., Walley K.R. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit. Care Med. 2011, 39:1641-1648.
22. Paul M., Poyan M.A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 2006, 86:747-803.
23. Randrianarison N., Clerici C., Ferreira C., Fontayne A., Pradervand S., Fowler-Jaeger N., Hummler E., Rossier B.C., Planès C. Low expression of the beta-ENaC subunit impairs lung fluid clearance in the mouse. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294:409-416.
24. Rateri D.L., Moorleghen J.J., Balakrishnan A., Owens A.P., Howatt D.A., Subramanian V., Poduri A., Charnigo R., Cassis L.A., Daugherty A. Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ. Res. 2011, 108:574-581.
25. Richardson M.A., Gupta A., O'Brien L.A., Berg D.T., Gerlitz B., Syed S., Sharma G.R., Cramer M.S., Heuer J.G., Galbreath E.J., Grinnell B.W. Treatment of sepsis-induced acquired protein C deficiency reverses angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response. J. Pharmacol. Exp. Ther. 2008, 325:17-26.
26. Saha S., Li Y., Anand-Srivastava M.B. Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 2008, 86:190L 198.
27. Sakuma T., Zhao Y., Sugita M., Sagawa M., Toga H., Ishibashi T., Nishio M., Matthay M.A. Malnutrition impairs alveolar fluid clearance in rat lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286(6):1268-1274.
28. Seybold J., Newton R., Wright L., Finney P.A., Suttorp N., Barnes P.J., Adcock I.M., Giembycz M.A. Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in β2-adrenoreceptor desensitization. J. Biol. Chem. 1998, 273:20575-20588.
29. Vivek B., Kenneth R.H. Mechanisms of ENaC regulation and clinical implications. J. Am. Soc. Nephrol. 2008, 19:1845-1854.
30. Wang Q., Horisberger J.D., Maillard M., Brunner H.R., Rossier B.C., Burnier M. Salt- and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice. Expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat. Am. J. Physiol. Clin. Exp. Pharmacol. Physiol. 2000, 27:60-66.
31. Ware L.B., Matthay M.A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001, 163:1376-1383.
32. Wiberg-Jørgensen F., Klausen N.O., Hald A., Qvist J., Giese J., Damkjaer Nielsen M. Pulmonary angiotensin II production in respiratory failure. Clin. Physiol. 1983, 3:59-67.
33. Yao S., Feng D., Wu Q., Li K., Wang L. Losartan attenuates ventilator-induced lung injury. J. Surg. Res. 2008, 145:25-32.